7 completed, 1 not yet recruiting. 8 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 7, Not yet recruiting 1 |
| Phase 2 | 2 | Completed 2 |
Follow Racivir: new trials by email Literature Review of Racivir trials Research Report on Racivir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Adaptive Platform Trial for Evaluation of Novel Treatment Regimens in Children and Adolescents With HIV in Africa Dolutegravir (DTG), Abacavir (ABC), Lamivudine (3TC) - HIV Infection | Phase 3 | Not yet recruiting | University College, London | 800 | 2026-11-01 | 2026-08-28 |
| The Women TAF-FTC Benchmark Study co-formulated 25mg TAF/ 200mg FTC - HIV Infections | Phase 2 / Phase 3 | Completed | University of Washington | 54 | 2023-04-10 | 2026-06-18 |
| A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of Care DRV 800 mg + COBI 150 mg + FTC 200 mg + TAF 10 mg FDC - HIV-1 | Phase 3 | Completed | Janssen Scientific Affairs, LLC | 109 | 2017-07-31 | 2025-02-04 |
| QoL and Adherence to One-pill Once-a-day HAART reduced number of pills - HIV Infection, HIV Infections | Phase 3 | Completed | A.O. Ospedale Papa Giovanni XXIII | 212 | 2008-04-01 | 2009-10-29 |
| Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207) Tenofovir (TDF), Emtricitabine (FTC), Efavirenz (EFV) - HIV Infection | Phase 3 | Completed | French National Agency for Research on AIDS and Viral Hepatitis | 40 | 2004-06-01 | 2007-07-03 |
| Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects Emtricitabine (FTC), Tenofovir Disoproxil Fumarate (TDF), Efavirenz (EFV) - HIV Infections | Phase 3 | Completed | Gilead Sciences | 517 | 2003-07-01 | 2010-10-13 |
| Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT), NNRTIs (EFV, NVP), PIs (AMP, IDV, LPV/r, NFV, SQV, RTV) - HIV Infections | Phase 2 / Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 266 | 2002-08-01 | 2021-11-05 |
| Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART emtricitabine, FTC (drug), didanosine, ddI (drug), efavirenz (drug) - HIV Infections | Phase 3 | Completed | ANRS, Emerging Infectious Diseases | 350 | 2001-04-01 | 2026-06-15 |
HIV Infections (7) · Acquired Immunodeficiency Syndrome (1)
A.O. Ospedale Papa Giovanni XXIII (1) · ANRS, Emerging Infectious Diseases (1) · French National Agency for Research on AIDS and Viral Hepatitis (1) · Gilead Sciences (1) · Janssen Scientific Affairs, LLC (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · University College, London (1) · University of Washington (1)
United States (3) · France (1) · Kenya (1) · Puerto Rico (1) · Senegal (1)
Andrew Cheng, MD, PhD (1) · Ann J. Melvin, MD (1) · Franco Maggiolo, MD (1) · Genevieve Chene, MD, PhD (1) · Jean-Michel Molina, MD, PhD (1) · Kenneth K Mugwanya, MBChB, MS, PhD (1) · Papa Salif Sow (1) · Peter L Anderson, PharmD (1) · Roland Landman (1) · Ross E. McKinney, Jr., MD (1)
PMID 15717256, PMID 16421366, PMID 21036772, PMID 21288774, PMID 31879782, PMID 33999786